^Betschel, Stephen D.; Banerji, Aleena; Busse, Paula J.; Cohn, Danny M.; Magerl, Markus (August 2023). "Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape". The Journal of Allergy and Clinical Immunology: In Practice. 11 (8): 2315–2325.
doi:
10.1016/j.jaip.2023.04.017.
PMID37116793.
S2CID258390214.
^Zanichelli, Andrea; Montinaro, Vincenzo; Triggiani, Massimo; Arcoleo, Francesco; Visigalli, Debora; Cancian, Mauro (3 April 2022). "Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency". Expert Opinion on Emerging Drugs. 27 (2): 103–110.
doi:
10.1080/14728214.2022.2105834.
PMID35876094.
S2CID251038265.
^Betschel, Stephen D.; Banerji, Aleena; Busse, Paula J.; Cohn, Danny M.; Magerl, Markus (August 2023). "Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape". The Journal of Allergy and Clinical Immunology: In Practice. 11 (8): 2315–2325.
doi:
10.1016/j.jaip.2023.04.017.
PMID37116793.
S2CID258390214.
^Zanichelli, Andrea; Montinaro, Vincenzo; Triggiani, Massimo; Arcoleo, Francesco; Visigalli, Debora; Cancian, Mauro (3 April 2022). "Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency". Expert Opinion on Emerging Drugs. 27 (2): 103–110.
doi:
10.1080/14728214.2022.2105834.
PMID35876094.
S2CID251038265.